LysoPC(20:3(8Z,11Z,14Z)/0:0)
|
Basic information |
| Metabolite name | LysoPC(20:3(8Z,11Z,14Z)/0:0) |
 | HMDB0010394 |
 |
C04230 |
 |
52924055 |
| Synonyms | 1-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine; |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | LysoPC(20:3(8Z,11Z,14Z)/0:0) |
| HMDB0010394 |
|
C04230 |
|
52924055 |
| Synonyms | 1-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine; |
| No. of studies | 3 |
|
Relationship between LysoPC(20:3(8Z,11Z,14Z)/0:0) and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Down |
| Study M743 | Type1 | CUS group vs. control group | Plasma | Sprague-Dawley rat | Down |